Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and ribavirin in recently acquired hepatitis C
NCT02156570Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Oct 2014
- Primary completion
- Aug 2017
- Countries
- 2
01
Overview
A Phase 4 trial of sofosbuvir in hepatitis C (HCV), sponsored by The Kirby Institute. Started Oct 2014; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02156570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02156570.